1. Home
  2. IMNM vs NPK Comparison

IMNM vs NPK Comparison

Compare IMNM & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • NPK
  • Stock Information
  • Founded
  • IMNM 2006
  • NPK 1905
  • Country
  • IMNM United States
  • NPK United States
  • Employees
  • IMNM N/A
  • NPK N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • NPK Ordnance And Accessories
  • Sector
  • IMNM Health Care
  • NPK Industrials
  • Exchange
  • IMNM Nasdaq
  • NPK Nasdaq
  • Market Cap
  • IMNM 945.8M
  • NPK 691.4M
  • IPO Year
  • IMNM 2020
  • NPK N/A
  • Fundamental
  • Price
  • IMNM $10.60
  • NPK $95.68
  • Analyst Decision
  • IMNM Strong Buy
  • NPK
  • Analyst Count
  • IMNM 5
  • NPK 0
  • Target Price
  • IMNM $26.40
  • NPK N/A
  • AVG Volume (30 Days)
  • IMNM 965.4K
  • NPK 147.7K
  • Earning Date
  • IMNM 08-11-2025
  • NPK 08-05-2025
  • Dividend Yield
  • IMNM N/A
  • NPK 1.03%
  • EPS Growth
  • IMNM N/A
  • NPK 31.39
  • EPS
  • IMNM N/A
  • NPK 5.96
  • Revenue
  • IMNM $10,938,000.00
  • NPK $415,214,000.00
  • Revenue This Year
  • IMNM N/A
  • NPK N/A
  • Revenue Next Year
  • IMNM $259.34
  • NPK N/A
  • P/E Ratio
  • IMNM N/A
  • NPK $16.24
  • Revenue Growth
  • IMNM N/A
  • NPK 23.15
  • 52 Week Low
  • IMNM $5.15
  • NPK $69.80
  • 52 Week High
  • IMNM $16.81
  • NPK $110.83
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 60.20
  • NPK 40.54
  • Support Level
  • IMNM $10.33
  • NPK $96.08
  • Resistance Level
  • IMNM $11.08
  • NPK $99.73
  • Average True Range (ATR)
  • IMNM 0.60
  • NPK 3.37
  • MACD
  • IMNM 0.04
  • NPK -1.73
  • Stochastic Oscillator
  • IMNM 72.31
  • NPK 5.08

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

Share on Social Networks: